Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr, a key indicator of kidney damage. 71% demonstrated improved or stabilized eGFR, signaling preserved...
Hence then, the article about palatin to present positive phase 2b data for melanocortin agonist in diabetic kidney disease at the national kidney foundation spring meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting )
Also on site :
- France to ditch American video conferencing services
- EU’s Kallas privately complaining about ‘dictator’ von der Leyen – Politico
- Lightning strikes pro-Bolsonaro rally in Brazil